pharmaceutical preparations for treatment of cancers; pharmaceutical preparations for treatment of benign tumors; pharmaceutical preparations for use in chemotherapy; and anti-inflammatories

pharmaceuticals, namely, proteasome inhibitors; and pharmaceutical preparations for treatment of myelomas, leukemias, and cancers; pharmaceutical preparations for use in chemotherapy